Literature DB >> 21802112

Organochlorine concentrations in breast milk and prevalence of allergic disorders in Japanese women.

Yoshihiro Miyake1, Keiko Tanaka, Yuko Masuzaki, Nobuyuki Sato, Yoshirou Ikeda, Youichi Chisaki, Masashi Arakawa.   

Abstract

Persistent organic pollutants have been shown to have immunomodulating effects in humans. However, epidemiological evidence regarding the relationships between organochlorine compound exposure and allergic disorders coming from studies of children has been limited and inconsistent. The current cross-sectional study examined the associations between the concentrations of β-hexachlorocyclohexane (HCH), hexachlorobenzene (HCB), p,p'-dichlorodiphenyldichloroethylene (DDE), and trans-nonachlordane in breast milk and the prevalence of allergic disorders in 124 adult Japanese women. The definition of wheeze and asthma was based on criteria from the European Community Respiratory Health Survey whereas that of eczema and rhinoconjunctivitis was based on criteria from the International Study of Asthma and Allergies in Childhood. Adjustment was made for age, smoking, family history of allergic disorders, and education. The prevalence values of wheeze, asthma, eczema, and rhinoconjunctivitis in the past 12 months were 9.7%, 4.8%, 13.7%, and 29.8%, respectively. The median concentrations of β-HCH, HCB, p,p'-DDE, and trans-nonachlordane in breast milk were 28.3, 7.0, 71.6, and 23.9 ng g(-1) lipid, respectively (range, 4.5-253, 2.1-14.5, 7.5-362, and 1.8-130 ng g(-1) lipid, respectively). When the exposures were treated as continuous variables, no significant associations were found between concentrations of HCB, β-HCH, p,p'-DDE, or trans-nonachlordane and the prevalence of wheeze, asthma, eczema, or rhinoconjunctivitis. Our results suggest that concentrations of β-HCH, HCB, p,p'-DDE, and trans-nonachlordane in breast milk are not evidently associated with the prevalence of wheeze, asthma, eczema, or rhinoconjunctivitis in young female Japanese adults. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802112     DOI: 10.1016/j.chemosphere.2011.07.001

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  5 in total

1.  Smoking and prevalence of allergic disorders in Japanese pregnant women: baseline data from the Kyushu Okinawa Maternal and Child Health Study.

Authors:  Keiko Tanaka; Yoshihiro Miyake; Masashi Arakawa
Journal:  Environ Health       Date:  2012-03-14       Impact factor: 5.984

2.  Spatial and temporal trends of the Stockholm Convention POPs in mothers' milk -- a global review.

Authors:  Johan Fång; Elisabeth Nyberg; Ulrika Winnberg; Anders Bignert; Åke Bergman
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-26       Impact factor: 4.223

3.  Maternal concentrations of persistent organochlorine pollutants and the risk of asthma in offspring: results from a prospective cohort with 20 years of follow-up.

Authors:  Susanne Hansen; Marin Strøm; Sjurdur F Olsen; Ekaterina Maslova; Panu Rantakokko; Hannu Kiviranta; Dorte Rytter; Bodil H Bech; Linda V Hansen; Thorhallur I Halldorsson
Journal:  Environ Health Perspect       Date:  2013-10-25       Impact factor: 9.031

4.  Maternal Health and Nutrition Status, Human Milk Composition, and Growth and Development of Infants and Children: A Prospective Japanese Human Milk Study Protocol.

Authors:  Keisuke Nojiri; Shunjiro Kobayashi; Satoshi Higurashi; Tomoki Takahashi; Yuta Tsujimori; Hiroshi M Ueno; Shiomi Watanabe-Matsuhashi; Yasuhiro Toba; Junichi Yamamura; Taku Nakano; Kyoko Nomura; Toshiya Kobayashi
Journal:  Int J Environ Res Public Health       Date:  2020-03-13       Impact factor: 3.390

5.  Estimated postnatal p,p'-DDT and p,p'-DDE levels and body mass index at 42 months of age in a longitudinal study of Japanese children.

Authors:  Laurence Plouffe; Delphine Bosson-Rieutort; Lina Madaniyazi; Miyuki Iwai-Shimada; Kunihiko Nakai; Nozomi Tatsuta; Shoji F Nakayama; Marc-André Verner
Journal:  Environ Health       Date:  2020-05-11       Impact factor: 5.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.